Make BIC’s Next Year Even More Impactful! Your Support and Tax-Deductible Gifts Are Vital! Although we dream of a future where BIC can close its doors because the medical field has wholeheartedly addressed benzodiazepine harm,…
Join Us Saturday, July 1 @ 11:30 am Eastern / 10:30 am Central / 9:30 am Mountain / 8:30 am Pacific on Facebook Live for a discussion about this paper. More information is available here. Long-term consequences…
As requested, a PDF of the poster is available here. On April 15th, our medical director, Christy Huff, presented a research poster at the 2023 American Society of Addiction Medicine (ASAM) Annual Conference in Washington,…
On January 26, Dr. Michael Bohan, who serves on our medical advisory board, operated our booth at the Medicating Normal Screening. Medicating Normal is an award-winning documentary telling the untold story of the potential long-term…
The second paper reporting data from the benzodiazepine experience survey is now available online. The survey was designed in 2018 by Dr. Jane Macoubrie, a professor of communications and member of BIC’s general advisory board,…
Our director presented her lived benzodiazepine experience as a keynote speaker for the California Society of Addiction Medicine’s 2022 conference, August 24 through the 27th. The California Society of Addiction Medicine is the largest state…
The benzodiazepine experience survey was designed by Dr. Jane Macoubrie, a professor of communications and member of BIC’s general advisory board, and Dr. Christy Huff, director of Benzodiazepine Information Coalition, who both have lived experience…
Please join the Colorado Consortium’s Benzodiazepine Action Work Group for our free CME lunch and learn webinar series. Webinar topics include alternative treatments to BZDs, consequences of BZD prescribed use, BZD Induced Neurologic Dysfunction (BIND),…
